IOL Chemicals receives Koran FDA approval for Ibuprofen and Fenofibrate

IOL Chemicals & Pharmaceuticals has received approval of Korean Ministry of Food and Drug Safety (Korean FDA) for Company's Pharmaceuticals API products 'IBUPROFEN and 'FENOFIBRATE'. The approval of Korean FDA re-establishes the Company's efforts to keep the highest quality standards and to increase presence in the regulated markets. This will strengthen Company's presence in South Korean market.

Powered by Capital Market - Live News